BR0108478A - Formulação nutritiva contendo substancias pré-bióticas - Google Patents

Formulação nutritiva contendo substancias pré-bióticas

Info

Publication number
BR0108478A
BR0108478A BR0108478-0A BR0108478A BR0108478A BR 0108478 A BR0108478 A BR 0108478A BR 0108478 A BR0108478 A BR 0108478A BR 0108478 A BR0108478 A BR 0108478A
Authority
BR
Brazil
Prior art keywords
formulation containing
nutritional formulation
prebiotic substances
containing prebiotic
substances
Prior art date
Application number
BR0108478-0A
Other languages
English (en)
Other versions
BRPI0108478B8 (pt
BRPI0108478B1 (pt
Inventor
Jeffrey L Wilson
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24012783&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0108478(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BR0108478A publication Critical patent/BR0108478A/pt
Publication of BRPI0108478B1 publication Critical patent/BRPI0108478B1/pt
Publication of BRPI0108478B8 publication Critical patent/BRPI0108478B8/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1307Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/20Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A23C9/203Dietetic milk products not covered by groups A23C9/12 - A23C9/18 containing bifidus-active substances, e.g. lactulose; containing oligosaccharides
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/244Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Abstract

"FORMULAçãO NUTRITIVA CONTENDO SUBST NCIAS PRé-BIóTICAS". Uma composição nutritiva é proporcionada, que compreende oligofrutose e sialilactose.
BRPI0108478A 2000-02-17 2001-02-15 composição nutritiva contendo substancias pré-bióticas BRPI0108478B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50600900A 2000-02-17 2000-02-17
PCT/US2001/004794 WO2001060346A2 (en) 2000-02-17 2001-02-15 Nutritional formulation containing prebiotic substances

Publications (3)

Publication Number Publication Date
BR0108478A true BR0108478A (pt) 2003-04-22
BRPI0108478B1 BRPI0108478B1 (pt) 2017-05-30
BRPI0108478B8 BRPI0108478B8 (pt) 2021-05-25

Family

ID=24012783

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0108478A BRPI0108478B8 (pt) 2000-02-17 2001-02-15 composição nutritiva contendo substancias pré-bióticas

Country Status (13)

Country Link
EP (1) EP1255449B2 (pt)
JP (1) JP2003522784A (pt)
CN (1) CN1229115C (pt)
AR (1) AR027450A1 (pt)
AT (1) ATE357854T1 (pt)
AU (1) AU2001238285A1 (pt)
BR (1) BRPI0108478B8 (pt)
CA (1) CA2400737C (pt)
DE (1) DE60127533D1 (pt)
MX (1) MXPA02008016A (pt)
PT (1) PT1255449E (pt)
TW (1) TWI265008B (pt)
WO (1) WO2001060346A2 (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1243273A1 (en) * 2001-03-22 2002-09-25 Societe Des Produits Nestle S.A. Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters
CN1703149A (zh) * 2002-10-11 2005-11-30 惠氏公司 包含共生菌物质的营养性配方制剂
US7951410B2 (en) * 2003-04-14 2011-05-31 Mead Johnson Nutrition Company Enteral compositions containing caseinoglycomacropeptide having an enhanced concentration of sialic acid
US7867541B2 (en) * 2003-04-14 2011-01-11 Mead Johnson Nutrition Company Compositions and methods of formulation for enteral formulas containing sialic acid
PT1638418E (pt) 2003-06-23 2012-09-20 Nestec Sa Suplementação de aminoácidos para um ecossistema de flora microbiana saudável
CN1852665B (zh) * 2003-09-18 2010-09-01 阿尔拉食品公司 婴儿配方乳品
WO2006012536A2 (en) 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
US7973021B2 (en) 2005-09-22 2011-07-05 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Immunomodulating agent in gut
WO2007051475A1 (en) * 2005-11-04 2007-05-10 Arla Foods Amba A concentrate derived from a milk product enriched in naturally occurring sialyllactose and a process for preparation thereof
US8277856B2 (en) 2008-03-27 2012-10-02 Morinaga Milk Industry Co., Ltd. Method of producing acidic lactic acid bacteria beverage
KR101116864B1 (ko) * 2008-08-01 2012-02-29 주식회사 베네비오 고지혈증, 지방간 또는 비만의 예방 또는 치료용 조성물
KR20170053733A (ko) 2009-02-24 2017-05-16 리터 파마슈티컬즈 인코오포레이티드 프리바이오틱 제제 및 사용 방법
NL2004200C2 (en) * 2010-02-05 2011-08-08 Friesland Brands Bv Use of sialyl oligosaccharides in weight management.
NL2004201C2 (en) 2010-02-05 2011-08-08 Friesland Brands Bv Use of sialyl oligosaccharides to modulate the immune system.
CN106072654A (zh) * 2010-04-27 2016-11-09 N·V·努特里奇亚 6’‑唾液酸化乳糖在婴儿和幼儿营养物中的用途
WO2011136636A1 (en) * 2010-04-27 2011-11-03 N.V. Nutricia Use of 6'-sialyl lactose in infant nutrition
WO2011137249A1 (en) 2010-04-28 2011-11-03 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
EP3756672A1 (en) 2010-12-31 2020-12-30 Abbott Laboratories Human milk oligosaccharides for modulating inflammation
SG10201603856PA (en) 2010-12-31 2016-07-28 Abbott Lab Methods For Decreasing The Incidence Of Necrotizing Enterocolitis In Infants, Toddlers, Or Children Using Human Milk Oligosaccharides
CA2822660C (en) * 2010-12-31 2021-09-07 Abbott Laboratories Synbiotic combination of probiotic and human milk oligosaccharides
SG191395A1 (en) 2010-12-31 2013-08-30 Abbott Lab Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
CA2822495C (en) 2010-12-31 2020-12-22 Abbott Laboratories Methods of using human milk oligosaccharides for improving airway respiratory health
SG191393A1 (en) 2010-12-31 2013-08-30 Abbott Lab Neutral human milk oligosaccharides to promote growth of beneficial bacteria
CN103379908B (zh) 2010-12-31 2020-02-14 雅培制药有限公司 使用人乳寡糖、维生素c和抗炎剂减少氧化应激的发病率的方法
MY192208A (en) 2010-12-31 2022-08-08 Abbott Lab Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
WO2012107865A2 (en) 2011-02-10 2012-08-16 Wyeth Llc Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk
RU2630299C2 (ru) 2011-06-20 2017-09-06 Г.Дж. Хайнц Компани Брэндс ЛЛК Композиции, способ и наборы для стимулирования мукозальной иммунной системы
CN104023560A (zh) 2011-08-29 2014-09-03 雅培制药有限公司 用于预防胃肠道损伤和/或促进胃肠道愈合的人乳寡糖
NL2007931C2 (en) 2011-12-07 2013-06-10 Friesland Brands Bv Methods for providing sialylated oligosaccharides and products obtainable thereby.
BR112017002627A2 (pt) 2014-08-18 2017-12-05 Nestec Sa prebióticos para reduzir o risco de obesidade no futuro

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5953834B2 (ja) * 1982-05-19 1984-12-27 明治製菓株式会社 ビフイズス菌増殖促進物質
MX9304638A (es) * 1992-07-31 1994-05-31 Neose Pharm Inc Composicion para tratar e inhibir las ulceras gastricas y duodenales.
CN1121311A (zh) * 1993-02-26 1996-04-24 扬·施塔芬·诺马克 应用低聚糖苷作为细菌粘连的抑制剂
JPH07258093A (ja) * 1994-03-23 1995-10-09 Morinaga Milk Ind Co Ltd 神経成長因子様剤
JP3501415B2 (ja) * 1994-03-30 2004-03-02 雪印乳業株式会社 ビフィズス菌および乳酸菌増殖促進剤
CN1129524A (zh) * 1994-09-09 1996-08-28 哈尔滨松花江第二乳品厂 婴幼儿阶段奶粉
US5849324A (en) * 1995-07-10 1998-12-15 Abbott Laboratories Use of indigestible oligosaccharides to reduce the incidence of otitis media in humans
US5827526A (en) 1995-07-11 1998-10-27 Abbott Laboratories Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans
DE19701382A1 (de) * 1997-01-16 1998-07-23 Nutricia Nv Kohlenhydratmischung
MXPA00012399A (es) * 1998-06-10 2003-07-14 Albert B Crum Complememnto nutricional profilactico y terapeutico para la creacion y mantenimiento de microflora intestinal protectora de la salud y mejoramiento del sistema inmunologico.
EP1104998A1 (en) * 1998-08-21 2001-06-13 Advanced Nutricional Foods Pty. Limited Composition

Also Published As

Publication number Publication date
CN1406111A (zh) 2003-03-26
TWI265008B (en) 2006-11-01
PT1255449E (pt) 2007-08-24
BRPI0108478B8 (pt) 2021-05-25
AR027450A1 (es) 2003-03-26
WO2001060346A2 (en) 2001-08-23
BRPI0108478B1 (pt) 2017-05-30
CA2400737A1 (en) 2001-08-23
EP1255449B1 (en) 2007-03-28
EP1255449A2 (en) 2002-11-13
AU2001238285A1 (en) 2001-08-27
ATE357854T1 (de) 2007-04-15
DE60127533D1 (de) 2007-05-10
WO2001060346A3 (en) 2002-01-17
MXPA02008016A (es) 2002-11-29
CN1229115C (zh) 2005-11-30
CA2400737C (en) 2010-12-14
EP1255449B2 (en) 2016-06-08
JP2003522784A (ja) 2003-07-29

Similar Documents

Publication Publication Date Title
BR0108478A (pt) Formulação nutritiva contendo substancias pré-bióticas
IL159086A0 (en) 3-aryl-5-aryl- [1, 2, 4] -oxadiazole derivatives and pharmaceutical compositions containing the same
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
BRPI0402760A (pt) Composição microbicida
AU2001290257A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001290257A2 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
HUP0402003A3 (en) Substituted 1,4-benzodiazepines, pharmaceutical compositions containing them and uses thereof
BR0015188A (pt) Composições farmacêuticas
PL362177A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
BR9710731A (pt) Dispensador interativo para produtos quimicos de uso pessoal ou produtos quimicos de cuidado pessoal que proporciona uma mensagem acionada pela proximidade do usu rio
IL155196A0 (en) Benzamide derivatives and pharmaceutical compositions containing the same
IL144879A0 (en) Hererocyclic biphenyl compounds and pharmaceutical compositions containing the same
PT1112266E (pt) 4-amino-2-aril-pirimidinas substituidas, sua preparacao, sua utilizacao e composicoes farmaceuticas que as contem.
IL152451A0 (en) 2-chloro-2-nitrophenylcarboxamide derivatives and pharmaceutical compositions containing the same
IL153123A0 (en) N-ureidoheterocycloalkyl-piperidine derivatives and pharmaceutical compositions containing the same
IL150383A0 (en) Glyburide and pharmaceutical compositions containing the same
DE60209929D1 (de) Succinate des 5,8,14-triazatetracycloä10.3.1.0 2,11 .0 4,9 ü-hexadeca-2(11),3,5,7,9,-pentaens und pharmazeutische zusammensetzungen
NO20020676L (no) Oral administreringsform som inneholder probiotiske mikroorganismer
IL160523A0 (en) PHARMACEUTICAL COMPOSITION COMPRISING GABAPENTIN OR AN ANALOGUE THEREOF AND AN alpha-AMINOAMIDE AND ITS ANALGESIC USE
HUP0103381A3 (en) Disubstituted maleimide compounds and medicinal utilization thereof and the pharmaceutical compositions containing the same
HUP0400179A3 (en) 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines, their use and pharmaceutical compositions containing them
NO20012727D0 (no) 3,4,5-trisubstituerte arylnitronforbindelser og farmasöytiske sammensetninger som inneholder samme
CO5580729A2 (es) Composiciones nutricionales que comprenden cistationina
BR0213536A (pt) Formulações de xarope de ribavirina
AU2001294240A1 (en) 2,2-diphenylbutanamide derivatives and medicines containing the same

Legal Events

Date Code Title Description
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA A CLASSIFICACAO DA INT. CL. : A61K 31/00 PARA INT. CL. :2010.1: A23L 1/09; A23L 1/30; A23L 1/302; A23C 9/152.

Ipc: A23L 1/09 (2010.01), A23L 1/30 (2010.01), A23L 1/3

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B25C Requirement related to requested transfer of rights

Owner name: WYETH (US)

Free format text: A FIM DE ATENDER A TRANSFERENCIA, REQUERIDA ATRAVES DA PETICAO NO 860130004992 DE 18/10/2013, E NECESSARIO ESCLARECER A DIVERGENCIA ENTRE O NOME DA EMPRESA TITULAR DO PEDIDO E O NOME DA EMPRESA CEDENTE.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 10 DA LPI.

B25D Requested change of name of applicant approved

Owner name: WYETH LLC (US)

B25A Requested transfer of rights approved

Owner name: NESTEC S.A (CH)

B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A23C 9/13 (2006.01), A23C 9/20 (2006.01), A23L 29/

B25A Requested transfer of rights approved
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 15/02/2001 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 15/02/2021